Lancaster Investment Management / MRNA
Lancaster Investment Management’s Moderna Inc Position
Does Lancaster Investment Management own Moderna Inc (MRNA)? Not currently — the last reported position was 46.5K shares worth $6M in Q2 2024; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$6M
Q2 2024
Shares
46.5K
% of Portfolio
+3.61%
Quarters Held
1
position exited
Position History MRNA
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2024 | 46.5K | $6M | +3.61% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Lancaster Investment Management’s full portfolio or all institutional holders of MRNA.